ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents.
Saved in:
| Title: | ESG‐1‐60 and ESG‐1‐61: Novel dopamine D |
|---|---|
| Authors: | Soler‐Cedeño, Omar1 (AUTHOR), Keegan, Bradley M.2,3 (AUTHOR), Alton, Hannah1 (AUTHOR), Bi, Guo‐Hua1 (AUTHOR), Linz, Emily1 (AUTHOR), Vogt, Caleb D.2 (AUTHOR), Gogarnoiu, Emma S.2 (AUTHOR), Shi, Lei3 (AUTHOR), Newman, Amy Hauck2 (AUTHOR) anewman@intra.nida.nih.gov, Xi, Zheng‐Xiong1 (AUTHOR) zxi@intra.nida.nih.gov |
| Source: | British Journal of Pharmacology. Jul2025, Vol. 182 Issue 13, p2997-3016. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
